Xuefei Huang

Founder & CSO at Iaso Therapeutics

Dr. Xuefei Huang is Iaso’s founder and CSO. He received his B.Sc. degree in chemistry from the University of Science & Technology of China in 1994. He earned his Ph.D. in 1999 from Columbia University, New York, and was a Postdoctoral associate at The Scripps Research Institute from 1999-2001 and at Columbia University from 2001-2002.

Dr. Huang is an MSU Foundation Professor at the Departments of Chemistry and Biomedical Engineering, Michigan State University. His research interests are focused on cutting edge carbohydrate chemistry and biology. A major aim is to investigate novel approaches to boost immune responses for next generation vaccines. In addition, his group is developing new methodologies for synthesis of complex glycans and glyco-conjugates, and interfacing carbohydrate chemistry with nanotechnology for molecular imaging and targeted drug delivery. He is excited to translate the vaccine technologies from bench to bedside through Iaso.

The Huang group research has been continuously supported by the National Institutes of Health and the National Science Foundation. He has won multiple awards, including the New Investigator Award, the Horace S. Isbell Award and the Melville L. Wolfrom Award from the American Chemical Society. He was elected a Fellow of the American Association for Advancement of Science, and a Fellow of the American Chemical Society.


Org chart

Sign up to view 0 direct reports

Get started